TipRanks
Advertisement
Advertisement

SMMT Stock Latest News

Analyst Maintains Hold on Summit Therapeutics as Ivonescimab Data Awaited and No Price Target Assigned
RatingsAnalyst Maintains Hold on Summit Therapeutics as Ivonescimab Data Awaited and No Price Target Assigned
2d ago
SMMT
Summit Therapeutics put volume heavy and directionally bearish
PremiumThe Fly
Summit Therapeutics put volume heavy and directionally bearish
3d ago
SMMT
Summit Therapeutics Highlights Positive Ivonescimab Phase III Survival Data
PremiumCompany Announcements
Summit Therapeutics Highlights Positive Ivonescimab Phase III Survival Data
10d ago
8K
SMMT
Summit Therapeutics reports updated OS results from Phase 3 Harmoni trial
PremiumThe Fly
Summit Therapeutics reports updated OS results from Phase 3 Harmoni trial
10d ago
SMMT
Summit Therapeutics Showcases Promising Ivonescimab Survival Data
PremiumCompany Announcements
Summit Therapeutics Showcases Promising Ivonescimab Survival Data
11d ago
8K
SMMT
Ivonescimab HARMONi-2 Survival Data De-Risk HARMONi-7; Buy Rating and $33 Price Target Reaffirmed on Summit Therapeutics
PremiumRatingsIvonescimab HARMONi-2 Survival Data De-Risk HARMONi-7; Buy Rating and $33 Price Target Reaffirmed on Summit Therapeutics
12d ago
SMMT
Summit partner announces updated data from Phase III HARMONi-2 trial
Premium
The Fly
Summit partner announces updated data from Phase III HARMONi-2 trial
12d ago
SMMT
Summit Therapeutics Advances Ivonescimab Combo Into Pivotal Bladder Cancer Trial
Premium
Company Announcements
Summit Therapeutics Advances Ivonescimab Combo Into Pivotal Bladder Cancer Trial
14d ago
SMMT
Uber initiated, Thermo Fisher upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Uber initiated, Thermo Fisher upgraded: Wall Street’s top analyst calls
16d ago
CI
DYN
Summit Therapeutics upgraded to Buy at Jefferies ahead of PFS data
PremiumThe Fly
Summit Therapeutics upgraded to Buy at Jefferies ahead of PFS data
16d ago
SMMT
Summit Therapeutics upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Summit Therapeutics upgraded to Buy from Hold at Jefferies
16d ago
SMMT
Summit Therapeutics Stock (SMMT) Rallies on Positive Clinical Trial Results
PremiumMarket News
Summit Therapeutics Stock (SMMT) Rallies on Positive Clinical Trial Results
22d ago
SMMT
Summit Therapeutics strengthened by positive ivonescimab survival results
PremiumCompany AnnouncementsSummit Therapeutics strengthened by positive ivonescimab survival results
22d ago
8K
SMMT
Summit Therapeutics: Ivonescimab’s Strengthened Survival Data Supports Buy Rating and Maintained $40 Price Target
Premium
Ratings
Summit Therapeutics: Ivonescimab’s Strengthened Survival Data Supports Buy Rating and Maintained $40 Price Target
22d ago
SMMT
Dynatrace, Fluence, Five Below, Summit, BNS Trending With Analysts
Premium
Weekend Updates
Dynatrace, Fluence, Five Below, Summit, BNS Trending With Analysts
27d ago
DT
BNS
Summit Therapeutics’ Ivonescimab Shows Phase III Survival Benefit
PremiumCompany Announcements
Summit Therapeutics’ Ivonescimab Shows Phase III Survival Benefit
30d ago
8K
SMMT
Summit: Akeso reports ‘positive’ results from Phase III HARMONi-GI11 study
PremiumThe Fly
Summit: Akeso reports ‘positive’ results from Phase III HARMONi-GI11 study
1M ago
SMMT
Summit announces publication of primary analysis results from Phase III HARMONi
PremiumThe Fly
Summit announces publication of primary analysis results from Phase III HARMONi
1M ago
SMMT
Summit Therapeutics upgraded to Market Perform from Underperform at Bernstein
PremiumThe Fly
Summit Therapeutics upgraded to Market Perform from Underperform at Bernstein
1M ago
SMMT
Summit Therapeutics falls -8.5%
PremiumThe FlySummit Therapeutics falls -8.5%
1M ago
SMMT
Balanced Risk-Reward on Summit Therapeutics as Ivonescimab Lung Cancer Data Show Weaker PFS but Encouraging Overall Survival, Supporting Hold Rating
Premium
Ratings
Balanced Risk-Reward on Summit Therapeutics as Ivonescimab Lung Cancer Data Show Weaker PFS but Encouraging Overall Survival, Supporting Hold Rating
1M ago
SMMT
Summit Therapeutics upgraded to Market Perform from Underperform at Leerink
Premium
The Fly
Summit Therapeutics upgraded to Market Perform from Underperform at Leerink
1M ago
SMMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >